Compare Freshworks Inc (FRSH) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Freshworks Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Freshworks Inc trades at $11.86 (market cap $3.31B), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 24.8× Freshworks Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Freshworks Inc pays none. Which is the better fit depends on your goals.
| FRSH | REGN | |
|---|---|---|
Market Cap | $3.31B | $82.06B |
Sector | Technology | Health |
52-Week High | $13.97 | $812.27 |
52-Week Low | $6.88 | $555.51 |
Enterprise Value | $2.68B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Freshworks Inc
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CX and ITSM categories, and have also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and better serve their customers and employees.
Read more on FRSH →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
